GLP-1 receptor agonists are transforming obesity and diabetes care, but gastrointestinal side effects remain one of the biggest challenges to treatment success. Nausea, constipation, diarrhea, bloating, reflux, and poor oral intake can significantly impact quality of life and lead to treatment discontinuation. In this evidence-based update, we'll review the latest research on GLP-1-related GI symptoms and discuss practical nutrition strategies to improve tolerance and adherence. We'll also explore emerging data on inadequate protein intake, micronutrient deficiencies, and lean mass loss—important risks that are often overlooked during GLP-1 therapy.

 

Join us for a clinically focused session packed with practical tools you can immediately apply to support patients using Ozempic®, Wegovy®, Mounjaro®, and other GLP-1 medications.

 

✔ Understand the mechanisms behind common GI side effects
✔ Manage nausea, constipation, diarrhea, bloating, and delayed gastric emptying
✔ Identify patients at risk of malnutrition and muscle loss
✔ Apply the latest nutrition recommendations to support long-term treatment success